GO
Loading...

Tamiflu and Cancer Drugs Boost Roche

Thursday, 11 Apr 2013 | 3:30 AM ET

Daniel O'Day, head of pharmaceutical operations at Roche, tells CNBC that the company haven't seen a huge effect from the Sequester in the US.